Dr. Salvatore Senzatimore Jr., MD

Dr. Senzatimore practices at Center for Gastrointestinal Endoscopy in West Palm Beach, Florida.

Dr. Senzatimore's NPI, 1962504969, was assigned on September 1, 2006. Dr. Senzatimore graduated from New York Medical College in 1989. Dr. Senzatimore holds Florida license ME60151.

Dr. Senzatimore's primary practice is Center for Gastrointestinal Endoscopy, at 1117 N Olive Ave, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (561) 514-0353.

Dr. Senzatimore's primary practice is Center for Gastrointestinal Endoscopy in West Palm Beach, Florida. Dr. Senzatimore is also affiliated with Good Samaritan Medical Center. The medical group on file is Gastro Health. Dmand AI also links Dr. Senzatimore to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Senzatimore practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Senzatimore's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Senzatimore is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Senzatimore is licensed in Florida.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Senzatimore treats.

CMS data shows 1,479 Medicare services from Dr. Senzatimore across 12 procedure codes in 2024, for 580 Medicare patients. Medicare paid $141,333 for them.

CMS counts 580 Medicare patients who saw Dr. Senzatimore in 2024. The largest group is 65 to 74, with 265 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Senzatimore's median patient age at 65, with 60% women.

In 2024, Dr. Senzatimore wrote 1,295 Medicare Part D claims for 530 patients. 76% of them were for generic drugs. CMS names the drug for 1,186 of them, across 19 drugs with 11 or more claims each, at $106,228 in total drug cost. In 2023, CMS named 1,037 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Senzatimore for performance year 2024, reported as part of a group. Dr. Senzatimore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Senzatimore as offering telehealth. CMS counts 124 procedures of colonoscopy by Dr. Senzatimore, more than 85% of the clinicians it reports for that procedure.

CMS Open Payments shows 311 general payments to Dr. Senzatimore from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Abbvie Inc. paid the most, $1,168.

Dmand AI lists 2 awards for Dr. Senzatimore, most recently CMS Stage 1 EHR in 2013.

Dr. Senzatimore graduated from New York Medical College in 1989.

Dr. Senzatimore is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.